Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments
10.1186/s12985-023-02195-9 · doi-reference
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients
10.1038/s41598-021-02701-5 · doi-reference
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
10.1038/s41392-020-00417-y · doi-reference
An SPM-enriched marine oil supplement shifted microglia polarization toward M2, ameliorating retinal degeneration in rd10 mice
10.3390/antiox12010098 · doi-reference
Androgen receptor is a determinant of melanoma targeted drug resistance
10.1038/s41467-023-42239-w · doi-reference
Fanconi anemia pathway as a prospective target for cancer intervention
10.1186/s13578-020-00401-7 · doi-reference
10.1245/s10434-022-11752-5
10.1245/s10434-022-11752-5 · doi-reference
CD44 as a tumor biomarker and therapeutic target
10.1186/s40164-020-00192-0 · doi-reference
Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations
10.1021/acs.jmedchem.0c00994 · doi-reference
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
10.1002/ijc.24005 · doi-reference
Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death
10.1016/j.pdpdt.2011.09.003 · doi-reference
Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells
10.1042/cbi20110103 · doi-reference
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
10.1016/j.humpath.2013.02.022 · doi-reference
Melanin content in melanoma metastases affects the outcome of radiotherapy
10.18632/oncotarget.7528 · doi-reference
10.1016/j.critrevonc.2016.12.003
10.1016/j.critrevonc.2016.12.003 · doi-reference
10.1038/nature05660
10.1038/nature05660 · doi-reference
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
10.1038/s41467-022-32754-7 · doi-reference
10.3390/cells10061334
10.3390/cells10061334 · doi-reference
P53 signaling in cancer progression and therapy
10.1186/s12935-021-02396-8 · doi-reference
10.3390/jcm10163760
10.3390/jcm10163760 · doi-reference
Targeting growth hormone in cancer: future perspectives
10.1530/erc-23-0033 · doi-reference
10.1016/s1074-7613(01)00094-2
10.1016/s1074-7613(01)00094-2 · doi-reference
10.12688/f1000research.17023.1
10.12688/f1000research.17023.1 · doi-reference
TNF patterns and tumor microenvironment characterization in head and neck squamous cell carcinoma
10.3389/fimmu.2021.754818 · doi-reference
Gefitinib and Afatinib show potential efficacy for Fanconi anemia–related head and neck cancer
10.1158/1078-0432.ccr-19-1625 · doi-reference
10.1016/j.exphem.2020.11.002
10.1016/j.exphem.2020.11.002 · doi-reference
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
10.20517/2394-4722.2017.03 · doi-reference
10.1111/j.1745-7254.2008.00889.x
10.1111/j.1745-7254.2008.00889.x · doi-reference
Inherited bone marrow failure syndromes: considerations pre- and posttransplant
10.1182/blood-2017-05-781799 · doi-reference
10.1016/j.gde.2015.07.002
10.1016/j.gde.2015.07.002 · doi-reference
10.1038/nrm.2016.48
10.1038/nrm.2016.48 · doi-reference
